Jennifer Kirk

Jennifer L. Kirk received her doctorate in biostatistics from the University of Washington in 2016. Prior to that, she completed a two-year post-baccalaureate fellowship at the National Institute of Allergy and Infectious Diseases in the Biostatistics Research Branch. In 2017, she joined the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research as a statistical reviewer of clinical and product quality/CMC statistics for vaccines, allergenics, and live biotherapeutics. In 2022, she transitioned to the Device and Non-Clinical Evaluation branch where she leads the product quality/CMC team for all of CBER’s products.